A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent
Jennifer Hardy, Stephanie Niman, Rebecca F. Goldfaden, Majdi Ashchi, Mohannad Bisharat, Jessica Huston, Heather Hartmann, Rushab Choksi
Topics & Concepts
MedicineEzetimibePCSK9Residual riskProprotein convertaseDiseasePharmacotherapyStatinInternal medicineKexinCoronary artery diseaseStroke (engine)Atherosclerotic cardiovascular diseaseLipoprotein(a)CardiologyDrugPharmacologyLipoproteinIntensive care medicineCholesterolLDL receptorMechanical engineeringEngineeringLipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism